Alfa 2 Interferon 2B (Intron-A)



Indications and Reactions:

Role Indications Reactions
Primary
Malignant Melanoma 30.8%
Melanoma 23.1%
Drug Therapy 15.4%
Hypertriglyceridaemia 15.4%
Depression 7.7%
Renal Cell Carcinoma Stage Unspecified 7.7%
Blood Creatine Phosphokinase Increased 15.5%
Hypophosphataemia 15.5%
White Blood Cell Count Decreased 9.7%
Vomiting 7.8%
Neutrophil Count Decreased 5.8%
Nausea 4.9%
Blood Triglycerides Increased 3.9%
Platelet Count Decreased 3.9%
Presyncope 3.9%
Erectile Dysfunction 2.9%
Hypokalaemia 2.9%
Lymphocyte Count Decreased 2.9%
Neuropsychiatric Syndrome 2.9%
Pain In Extremity 2.9%
Pancreatitis 2.9%
Urinary Tract Infection 2.9%
Weight Decreased 2.9%
Blood Sodium Decreased 1.9%
Cutaneous Lupus Erythematosus 1.9%
Herpes Zoster 1.9%